» Articles » PMID: 34645698

COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis

Overview
Specialty Nephrology
Date 2021 Oct 14
PMID 34645698
Citations 30
Authors
Affiliations
Soon will be listed here.
Citing Articles

18-month longitudinal SARS COV-2 neutralizing antibody dynamics in haemodialysis patients receiving heterologous 3-dose vaccination (AZD-1222- AZD-1222- BNT162b2) in a lower middle income setting.

Karunathilake R, Kumara R, Karunathilaka A, Wazil A, Nanayakkara N, Bandara C BMC Nephrol. 2024; 25(1):176.

PMID: 38778281 PMC: 11112903. DOI: 10.1186/s12882-024-03599-7.


Safety and Immunogenicity of the Convacell Recombinant N Protein COVID-19 Vaccine.

Rabdano S, Ruzanova E, Makarov D, Vertyachikh A, Teplykh V, Rudakov G Vaccines (Basel). 2024; 12(1).

PMID: 38276672 PMC: 10821050. DOI: 10.3390/vaccines12010100.


COVID-19 incidence and outcomes among patients with kidney replacement therapy.

Changsirikulchai S, Sangthawan P, Janma J, Rajborirug S, Ingviya T Kidney Res Clin Pract. 2023; 42(5):649-659.

PMID: 37813525 PMC: 10565457. DOI: 10.23876/j.krcp.22.240.


Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse.

Hsu C, Weiner D, Manley H, Li N, Miskulin D, Harford A Kidney Med. 2023; 5(11):100718.

PMID: 37786901 PMC: 10542005. DOI: 10.1016/j.xkme.2023.100718.


COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future.

Rouphael N, Bausch-Jurken M J Infect Dis. 2023; 228(Suppl 1):S46-S54.

PMID: 37539761 PMC: 10401621. DOI: 10.1093/infdis/jiad162.


References
1.
Feng S, Phillips D, White T, Sayal H, Aley P, Bibi S . Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021; 27(11):2032-2040. PMC: 8604724. DOI: 10.1038/s41591-021-01540-1. View

2.
De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye M, De Vriese A . Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study. J Am Soc Nephrol. 2020; 32(2):385-396. PMC: 8054894. DOI: 10.1681/ASN.2020060875. View

3.
Anand S, Montez-Rath M, Han J, Garcia P, Cadden L, Hunsader P . Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis. J Am Soc Nephrol. 2021; 32(10):2435-2438. PMC: 8722791. DOI: 10.1681/ASN.2021050611. View

4.
Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A . Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021; 385(7):661-662. PMC: 8262620. DOI: 10.1056/NEJMc2108861. View

5.
Ducloux D, Colladant M, Chabannes M, Yannaraki M, Courivaud C . Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis. Kidney Int. 2021; 100(3):702-704. PMC: 8243640. DOI: 10.1016/j.kint.2021.06.025. View